Press ROOM

CAR-T cell therapy involves taking a patient's immune cells (T cells), and engineering them in a laboratory to produce a special structure called a Chimeric Antigen Receptor (CAR). This structure enables the T cells to recognize and attack cancer cells.

CAR-T cell therapy involves taking a patient's immune cells (T cells), and engineering them in a laboratory to produce a special structure called a Chimeric Antigen Receptor (CAR). This structure enables the T cells to recognize and attack cancer cells.

Science series

While some risk factors are beyond our control, such as genetic makeup and age, adopting a healthy lifestyle and making informed dietary choices can significantly contribute to preventing the onset of cancer.

Living in a low-resource context can have a significant negative impact on health outcomes, according to recent research. Individuals living in areas with lower income, education, employment, and housing quality have been found to have lower survival rates when diagnosed with cancer.

Social series

Breast cancer is the most common malignant tumor and the main cause of death in women worldwide. With increased knowledge regarding tumor escape mechanisms and advances in immunology, many new antitumor strategies make immunotherapy a promising approach for the treatment of this disease.

ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin...

Research articles

JCWO´s mission is to provide free access to modern diagnostics and innovative treatments to those who need it most, while training new generations of professionals.

Jacinto Convit World Organization (JCWO) invites you to an exclusive charity event to be held at the charming Gisselle restaurant, located in the heart of Madrid, Spain, on Tuesday, November 19, 2024.

JCWO insights

Terms of use          Privacy policy